Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the USA, with Cook assuming commercial responsibilities for the Bentley product in the coming months.
The BeBack device is designed for steering through chronic total occlusions (CTO) and provides targeted re-entry options.
“The BeBack crossing catheter is an effective approach for successful recanalisation and should be available in every lab across the USA,” said Martijn Nugteren, director of sales and marketing at Bentley. “Thanks to this collaboration with Cook, we will now have a better commercial footprint in the USA with even more opportunities to treat patients with debilitating arterial and venous disease.”
Cook and Bentley have a long history of collaboration aimed at advancing patient care, A Bentely press release noted.
“We are excited to welcome Bentley’s BeBack crossing catheter to our peripheral intervention portfolio,” said Alec Cerchiari, Cook’s director of product management for peripheral arterial disease (PAD) and venous. “The BeBack crossing catheter is a unique tool for crossing heavily calcified lesions in antegrade or retrograde fashion.”
